AAAAAA
Results: 26-50/64
Authors:
Fulda, S
Debatin, KM
Citation: S. Fulda et Km. Debatin, Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors, MED PED ONC, 35(6), 2000, pp. 616-618
Authors:
Jeremias, I
Reinhardt, D
Debatin, KM
Citation: I. Jeremias et al., Irregular apoptosis as basis of disease, MONATS KIND, 148(8), 2000, pp. 795-804
Authors:
Van Valen, F
Fulda, S
Truckenbrod, B
Eckervogt, V
Sonnemann, J
Hillmann, A
Rodl, R
Hoffmann, C
Winkelmann, W
Schafer, L
Dockhorn-Dworniczak, B
Wessel, T
Boos, J
Debatin, KM
Jurgens, H
Citation: F. Van Valen et al., Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), INT J CANC, 88(2), 2000, pp. 252-259
Authors:
Wabitsch, M
Heinze, E
Debatin, KM
Blum, WF
Citation: M. Wabitsch et al., IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes, HORMONE MET, 32(11-12), 2000, pp. 555-559
Authors:
Jeremias, I
Kupatt, C
Martin-Villalba, A
Habazettl, H
Schenkel, J
Boekstegers, P
Debatin, KM
Citation: I. Jeremias et al., Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia, CIRCULATION, 102(8), 2000, pp. 915-920
Authors:
Fulda, S
Meyer, E
Debatin, KM
Citation: S. Fulda et al., Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression, CANCER RES, 60(14), 2000, pp. 3947-3956
Authors:
Beltinger, C
Fulda, S
Kammertoens, T
Uckert, W
Debatin, KM
Citation: C. Beltinger et al., Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis, CANCER RES, 60(12), 2000, pp. 3212-3217
Authors:
Muller, SM
Kohn, T
Schulz, AS
Debatin, KM
Friedrich, W
Citation: Sm. Muller et al., Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined Immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation, BLOOD, 96(13), 2000, pp. 4344-4349
Authors:
Fulda, S
Strauss, G
Meyer, E
Debatin, KM
Citation: S. Fulda et al., Functional CD95 Ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells, BLOOD, 95(1), 2000, pp. 301-308
Authors:
Li, X
Wang, Y
Debatin, KM
Hug, H
Citation: X. Li et al., The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells, BIOC BIOP R, 277(2), 2000, pp. 513-517
Authors:
Debatin, KM
Citation: Km. Debatin, The role of CD95 system in chemotherapy, DRUG RESIST, 2(2), 1999, pp. 85-90
Authors:
Bernassola, F
Scheuerpflug, C
Herr, I
Krammer, PH
Debatin, KM
Melino, G
Citation: F. Bernassola et al., Induction of apoptosis by IFN gamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit, CELL DEAT D, 6(7), 1999, pp. 652-660
Authors:
Friesen, C
Fulda, S
Debatin, KM
Citation: C. Friesen et al., Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells, CELL DEAT D, 6(5), 1999, pp. 471-480
Authors:
Herr, I
Wilhelm, D
Meyer, E
Jeremias, I
Angel, P
Debatin, KM
Citation: I. Herr et al., JNK/SAPK activity contributes to TRAIL-induced apoptosis, CELL DEAT D, 6(2), 1999, pp. 130-135
Authors:
Fulda, S
Lutz, W
Schwab, M
Debatin, KM
Citation: S. Fulda et al., MycN sensitizes neuroblastoma cells for drug-induced apoptosis, ONCOGENE, 18(7), 1999, pp. 1479-1486
Authors:
Posovszky, C
Friesen, C
Herr, I
Debatin, KM
Citation: C. Posovszky et al., Chemotherapeutic drugs sensitize pre-E ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis, LEUKEMIA, 13(3), 1999, pp. 400-409
Authors:
Classen, CF
Fulda, S
Friesen, C
Debatin, KM
Citation: Cf. Classen et al., Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity, LEUKEMIA, 13(3), 1999, pp. 410-418
Authors:
Friesen, C
Fulda, S
Debatin, KM
Citation: C. Friesen et al., Cytotoxic drugs and the CD95 pathway, LEUKEMIA, 13(11), 1999, pp. 1854-1858
Authors:
Bohler, T
Walcher, J
Holzl-Wenig, G
Schnitzler, P
Geiss, M
Buchholz, B
Linde, R
Rutschle, H
Debatin, KM
Citation: T. Bohler et al., Expression of CD69 on T-cells from HIV-1-infected children and adolescentsincreases with increasing viral load, EUR J PED, 158(8), 1999, pp. 638-644
Authors:
Pavlovic, M
Holl, RW
Haeberle, U
Schwarz, K
Heinze, E
Debatin, KM
Lang, D
Citation: M. Pavlovic et al., Angiotensin I converting enzyme and angiotensinogen gene polymorphisms related to 24-h blood pressure in paediatric type I diabetes mellitus, EUR J PED, 158(1), 1999, pp. 18-23
Authors:
Holl, RW
Bucher, P
Sorgo, W
Heinze, E
Homoki, J
Debatin, KM
Citation: Rw. Holl et al., Suppression of growth hormone by oral glucose in the evaluation of tall stature, HORMONE RES, 51(1), 1999, pp. 20-24
Authors:
Fulda, S
Jeremias, I
Pietsch, T
Debatin, KM
Citation: S. Fulda et al., Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors, KLIN PADIAT, 211(4), 1999, pp. 319-322
Authors:
Martin-Villalba, A
Herr, I
Jeremias, I
Hahne, M
Brandt, R
Vogel, J
Schenkel, J
Herdegen, T
Debatin, KM
Citation: A. Martin-villalba et al., CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons, J NEUROSC, 19(10), 1999, pp. 3809-3817
Authors:
Bohler, T
Walcher, J
Holzl-Wenig, G
Geiss, M
Buchholz, B
Linde, R
Debatin, KM
Citation: T. Bohler et al., Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents, AIDS, 13(7), 1999, pp. 779-789
Authors:
Muller, SM
Schulz, AS
Reiss, UM
Schwarz, K
Schreiner, T
Wiesneth, M
Debatin, KM
Friedrich, W
Citation: Sm. Muller et al., Definition of a critical T cell threshold for prevention of GVHD after HLAnon-identical PBPC transplantation in children, BONE MAR TR, 24(6), 1999, pp. 575-581